These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17153872)

  • 61. Using comparative effectiveness research to inform decision-making: is there a role of economic evaluation?
    Callahan KP; Bridges JF
    J Comp Eff Res; 2012 Jul; 1(4):299-301. PubMed ID: 24237460
    [No Abstract]   [Full Text] [Related]  

  • 62. [Cost of illness studies as a basis for decision making].
    Henke KD; Martin K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Jan; 49(1):19-27. PubMed ID: 16341605
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Priority setting and the ethics of resource allocation within VA healthcare facilities: results of a survey.
    Foglia MB; Pearlman RA; Bottrell MM; Altemose JA; Fox E
    Organ Ethic; 2008; 4(2):83-96. PubMed ID: 18839751
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expanding the Scope of Costs and Benefits for Economic Evaluations in Health: Some Words of Caution.
    McCabe C
    Pharmacoeconomics; 2019 Apr; 37(4):457-460. PubMed ID: 30328562
    [No Abstract]   [Full Text] [Related]  

  • 66. Review: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Goettsch WG; Enzing J
    Value Health; 2014; 17(1):1-2. PubMed ID: 24438710
    [No Abstract]   [Full Text] [Related]  

  • 67. [Econometric decisions in public health].
    Negrete J
    Salud Publica Mex; 1984; 26(4):415-20. PubMed ID: 6435264
    [No Abstract]   [Full Text] [Related]  

  • 68. Health dynamics: implications for efficiency and equity in priority setting.
    Hauck K; Tsuchiya A
    Value Health; 2011; 14(2):387-9. PubMed ID: 21402306
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis.
    Groot Koerkamp B; Hunink MG; Stijnen T; Hammitt JK; Kuntz KM; Weinstein MC
    Med Decis Making; 2007; 27(2):101-11. PubMed ID: 17409361
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [German recommendations for health economic evaluation. Revised edition of the Hannoverian consensus. Hannoverian Consensus Group].
    Dtsch Med Wochenschr; 1999 Dec; 124(49):1503-6. PubMed ID: 10629671
    [No Abstract]   [Full Text] [Related]  

  • 71. Health economics methods for public health resource allocation: a qualitative interview study of decision makers from an English local authority.
    Frew E; Breheny K
    Health Econ Policy Law; 2020 Jan; 15(1):128-140. PubMed ID: 30632474
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost-effectiveness decision making and US public opinion.
    Botta MD; Blendon RJ; Benson JM
    JAMA Intern Med; 2014 Jan; 174(1):141-3. PubMed ID: 24100698
    [No Abstract]   [Full Text] [Related]  

  • 73. An update on the health economics of asthma and allergy.
    Lee TA; Weiss KB
    Curr Opin Allergy Clin Immunol; 2002 Jun; 2(3):195-200. PubMed ID: 12045414
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cost effective clinical decision making and the medical care manager.
    Neuhauser D
    Hosp Health Serv Adm; 1980; 25(3):55-61. PubMed ID: 10309227
    [No Abstract]   [Full Text] [Related]  

  • 75. [How to make money? You are a county council's chief physician].
    Andrén-Sandberg A
    Lakartidningen; 2003 Sep; 100(39):3060-3. PubMed ID: 14560672
    [No Abstract]   [Full Text] [Related]  

  • 76. Why is it difficult to evaluate the effectiveness and cost-effectiveness of complex public health interventions in the community? A health economics perspective.
    Perspect Public Health; 2017 Jul; 137(4):206-207. PubMed ID: 28675333
    [No Abstract]   [Full Text] [Related]  

  • 77. Cost-effectiveness analysis in oncology.
    Earle CC; Coyle D; Evans WK
    Ann Oncol; 1998 May; 9(5):475-82. PubMed ID: 9653486
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations.
    Turner HC; Archer RA; Downey LE; Isaranuwatchai W; Chalkidou K; Jit M; Teerawattananon Y
    Front Public Health; 2021; 9():722927. PubMed ID: 34513790
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Introduction to health economics for the medical practitioner.
    Kernick DP
    Postgrad Med J; 2003 Mar; 79(929):147-50. PubMed ID: 12697913
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Estimating productivity costs in health economic evaluations: a review of instruments and psychometric evidence.
    Tang K
    Pharmacoeconomics; 2015 Jan; 33(1):31-48. PubMed ID: 25169062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.